Skip to main content
. 2020 Jan 23;75(4):1006–1013. doi: 10.1093/jac/dkz546

Table 2.

Pharmacokinetic parameter estimates for the structural and final models

Parameter Structural model (RSE %) [95% CI] Final model (RSE %) [95% CI]
CL (L/h) 8.42 (9.3) [7.0–10.0]
CL70kg×TBW70θ1
  CL70kg (L/h) 5.83 (4.4) [5.33–6.27]
  θ1 0.54 (26) [0.26–0.78]
Q (L/h) 51.9 (27) [30.0–83.0] 60.3 (19) [41.2–85.8]
V c (L) 222 (11) [182–267]
V c; 70kg ×TBW70θ2
Vc; 70kg (L) 150 (12) [119–187]
  θ2 0.77 (24) [0.40–1.12]
V p (L) 132 (9.3) [109–153]
V p; 70kg ×TBW70θ3
Vp; 70kg (L) 96.2 (12) [73.7–118]
  θ3 1.16 (18) [0.779–1.56]
Inter-individual variability (%)a
  CLb 37.1 (19) [25.0–55.2]
Vcb 44.4 (17) [33.0–66.2] 29.5 (16) [22.2–42.6]
Residual error (%)
  σpropb 17.6 (5.4) [16.0–19.6] 16.4 (5.1) [15.1–18.2]
OFV −506.2 −589.8

Q, inter-compartmental CL between Vc and Vp; σprop, proportional residual error; RSE, relative standard error based on covariance step in NONMEM; 95% CI, 95% CI obtained from the SIR procedure.

a

Calculated as eω2-1.

b

η and ε shrinkage of inter-individual variability and residual error are <10%.